Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reversible Cerebral Vasoconstriction Syndrome Associated With Fluoxetine
Tessa Manning, Christine Bartow, Michael R. Dunlap, et al.
Journal of the Academy of Consultation-Liaison Psychiatry (2021) Vol. 62, Iss. 6, pp. 634-644
Closed Access | Times Cited: 12

Showing 12 citing articles:

Reversible cerebral vasoconstriction syndrome: literature review
Michelle Zonkowski Ribas, Gabriela Ferreira Paticcié, Sara Diógenes Peixoto de Medeiros, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2023) Vol. 59, Iss. 1
Open Access | Times Cited: 23
RCVS: by clinicians for clinicians—a narrative review
Deborah Katharina Erhart, Albert C. Ludolph, Katharina Althaus
Journal of Neurology (2022) Vol. 270, Iss. 2, pp. 673-688
Open Access | Times Cited: 28
Clinical Characteristics of COVID-19-Related Reversible Cerebral Vasoconstriction Syndrome: A Systematic Review of Case Series
Raon Jung, Yun-Seo Oh, Soyoun Choi, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 487-487
Open Access
Drugs associated with reversible cerebral vasoconstriction syndrome: A pharmacovigilance study in vigiBase®
Sylvie Favrelière, Julien Mahé, G. Veyrac, et al.
Cephalalgia (2024) Vol. 44, Iss. 8
Open Access | Times Cited: 2
Side effects of antidepressants
Aaron Salwan, Daniel Greer, Megan Maroney, et al.
Side effects of drugs annual (2022), pp. 25-36
Closed Access | Times Cited: 8
Treatment-Related Reversible Cerebral Vasoconstriction Syndrome
G Avola, Alessandro Pezzini
Journal of Clinical Medicine (2024) Vol. 13, Iss. 19, pp. 5930-5930
Open Access | Times Cited: 1
Reversible Cerebral Vasoconstriction Syndrome Associated with Oxybutynin Use; a Brief Review of Pathophysiology
Wahab J Khan, Muhammad Asif, Sadia Aslam, et al.
Journal of Community Hospital Internal Medicine Perspectives (2023) Vol. 13, Iss. 4
Open Access | Times Cited: 1
Reversible cerebral vasoconstriction syndrome: Considerable differential diagnosis
Srijamya, Ruba Nageh Mehany Hemaya, Arjun Jay Prakash, et al.
Medicine India (2023) Vol. 2, pp. 1-1
Open Access
‘Diagnostic anchoring’ and a delayed diagnosis of reversible cerebral vasoconstriction syndrome
Shiwei Huang, Cameron Williams, James Thomas, et al.
BMJ Case Reports (2023) Vol. 16, Iss. 5, pp. e252540-e252540
Closed Access
Case report: Meningitis: a cause of reversible cerebral vasoconstriction syndrome?
F. Oukhai, Valérie Domigo, Joseph Benzakoun, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access
Reversible cerebral vasoconstriction syndrome associated with probable drug poisoning
Arthur de Oliveira Veras, Felipe Micelli Noleto, Michelle Zonkowski Ribas, et al.
Radiology Case Reports (2022) Vol. 18, Iss. 3, pp. 844-849
Open Access
Fluoxetine

Reactions Weekly (2021) Vol. 1875, Iss. 1, pp. 143-143
Closed Access
Page 1

Scroll to top